HC-067047
CAS No. 883031-03-6
HC-067047( HC-067047 | HC 067047 | HC067047 )
Catalog No. M19226 CAS No. 883031-03-6
HC-067047 is a potent and selective TRPV4 antagonist.Also inhibits the endogenous TRPV4-mediated response to 4α-PDH .
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 56 | In Stock |
|
| 10MG | 88 | In Stock |
|
| 25MG | 178 | In Stock |
|
| 50MG | 295 | In Stock |
|
| 100MG | 475 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameHC-067047
-
NoteResearch use only, not for human use.
-
Brief DescriptionHC-067047 is a potent and selective TRPV4 antagonist.Also inhibits the endogenous TRPV4-mediated response to 4α-PDH .
-
DescriptionHC-067047 is a potent and selective TRPV4 antagonist. HC-067047 increases functional bladder capacity and reduces micturition frequency in WT mice and rats with cystitis. HC-067047 did not affect bladder function in Trpv4(-/-) mice, demonstrating that its in vivo effects are on target. HC-067047 may provide a promising means of treating bladder
-
In VitroHC-067047 (1 μM; 24 hours; HEI-OC1 cells) treatment significantly decreases mRNA expression in high glucose cultured HEI-OC1 cells.?HC-067047 (1 μM; 24 hours; HEI-OC1 cells) treatment significantly decreases the expression of TRPV4 protein.HC-067047 (1 μM; 48 hours; HEI-OC1 cells) treatment inhibits cell proliferation.HC-067047 (1 μM; 48 hours; HEI-OC1 cells) treatment promotes cell apoptosis. RT-PCR Cell Line:HEI-OC1 cells Concentration:1 μM Incubation Time:24 hours Result:The mRNA expression was significantly decreased.Western Blot Analysis Cell Line:HEI-OC1 cells Concentration:1 μM Incubation Time:24 hours Result:The expression of TRPV4 protein was significantly decreased.Cell Proliferation Assay Cell Line:HEI-OC1 cells Concentration:1 μM Incubation Time:48 hours Result:Inhibited cell proliferation.Apoptosis Analysis Cell Line:HEI-OC1 cells Concentration:1 μM Incubation Time:48 hoursResult:Promoted cell apoptosis.
-
In VivoAnimal Model:Cyclophosphamide-treated WT and Trpv4?/? mice, and naive WT miceDosage:0 mg/kg, 1 mg/kg, 10 mg/kg, 50 mg/kg Administration:Intraperitoneal injection; for 30 minutes Result:Increased functional bladder capacity and reduces micturition frequency in WT mice with cystitis and did not affect bladder function in Trpv4?/? mice.
-
SynonymsHC-067047 | HC 067047 | HC067047
-
PathwayOthers
-
TargetOther Targets
-
RecptorhTRPV4/mTRPV4
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number883031-03-6
-
Formula Weight471.51
-
Molecular FormulaC26H28F3N3O2
-
Purity>98% (HPLC)
-
SolubilityDMSO : 50 mg/mL 106.04 mM
-
SMILESFC(F)(F)c1cc(ccc1)NC(=O)c4cc(c2ccccc2)n(CCCN3CCOCC3)c4C
-
Chemical Name2-Methyl-1-[3-(4-morpholinyl)propyl]-5-phenyl-N-[3-(trifluoromethyl)phenyl]-1H-pyrrole-3-carboxamide
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Everaerts W et al. Inhibition of the cation channel TRPV4 improves bladder function in mice and rats with cyclophosphamide-induced cystitis.Proc Natl Acad Sci U S A. 2010 Nov 2;107(44):19084-9.
molnova catalog
related products
-
Linzagolix choline
Linzagolix choline is an orally available non-peptide gonadotropin-releasing hormone (GnRH) antagonist. It can be used to study pain associated with uterine fibroids and endometriosis.
-
Benzylamine hydrochl...
Benzylamine hydrochloride, made of benzylamine and hydrochloric acid, is used to treat motion sickness and ascariasis, with antiemesis properties.
-
Cirsiliol
Cirsiliol is a selective inhibitor of 5-lipoxygenase and a competitive low-affinity ligand of benzodiazepine receptors.
Cart
sales@molnova.com